Quinn Anthony

EVP, CMO, & Head of R&D at SYNAGEVA BIOPHARMA CORP · on record since Jun 23, 2015
Director at Spyre Therapeutics, Inc. · on record since Apr 12, 2016
President & CEO at Spyre Therapeutics, Inc. · on record since Dec 10, 2018
Director at Kaleido Biosciences, Inc. · on record since Feb 27, 2019
Director at Generation Bio Co. · on record since Jun 18, 2020

Insider trading activity of Quinn Anthony

Transactions on record: 162; since Dec 22, 2011

Open-market buys: 29; $2.5M

Open-market sells: 20; $10.7M

Companies traded: 4; last filing Feb 9, 2026

Figures computed from official regulatory filings — .

Companies where Quinn Anthony has traded

Generation Bio Co.21 tx · $328K · Feb 9, 2026
Spyre Therapeutics, Inc.67 tx · $3.5M · Mar 18, 2022
Kaleido Biosciences, Inc.4 tx · Jul 1, 2021
SYNAGEVA BIOPHARMA CORP70 tx · $11.9M · Jun 23, 2015

Track record of Quinn Anthony

Statistical track record

Free account

Open-market buys: 29

Last buy: Jan 13, 2025

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Quinn Anthony

Co-insiders of Quinn Anthony

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Generation Bio Co.Listing unverified	Feb 9, 2026	OtherD (derivative)	-1,920	—	n/a (No price was disclosed in the filing)		SEC
Generation Bio Co.Listing unverified	Feb 9, 2026	OtherD (derivative)	-6,000	—	n/a (No price was disclosed in the filing)		SEC
Generation Bio Co.Listing unverified	Feb 9, 2026	OtherD (derivative)	-1,500	—	n/a (No price was disclosed in the filing)		SEC
Generation Bio Co.Listing unverified	Feb 9, 2026	Other	-29,928	—	n/a (No price was disclosed in the filing)		SEC
Generation Bio Co.Listing unverified	Feb 9, 2026	OtherD (derivative)	-2,500	—	n/a (No price was disclosed in the filing)		SEC
Generation Bio Co.Listing unverified	Feb 9, 2026	OtherD (derivative)	-3,000	—	n/a (No price was disclosed in the filing)		SEC
Generation Bio Co.Listing unverified	Feb 9, 2026	Other	-7,283	—	n/a (No price was disclosed in the filing)		SEC
Generation Bio Co.Listing unverified	Feb 9, 2026	OtherD (derivative)	-5,200	—	n/a (No price was disclosed in the filing)		SEC
Generation Bio Co.Listing unverified	Jun 6, 2025	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Generation Bio Co.Listing unverified	Jan 14, 2025	Buy	125,791	0.96 USD	$120.8K	conv 64First in 12mo	SEC
Generation Bio Co.Listing unverified	Jan 14, 2025	Buy	85,000	0.97 USD	$82.5K	conv 36	SEC
Generation Bio Co.Listing unverified	Jun 10, 2024	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Generation Bio Co.Listing unverified	Dec 5, 2023	Buy	88,495	1.41 USD	$124.8K	conv 62ClusterFirst in 12mo	SEC
Generation Bio Co.Listing unverified	Jun 12, 2023	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Generation Bio Co.Listing unverified	Jun 13, 2022	AwardD (derivative)	19,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Spyre Therapeutics, Inc.Listing on record	Mar 18, 2022	Buy	80,079	2.34 USD	$187.4K	conv 43	SEC
Spyre Therapeutics, Inc.Listing on record	Mar 15, 2022	Buy	42,417	1.86 USD	$78.9K	conv 35	SEC
Spyre Therapeutics, Inc.Listing on record	Mar 15, 2022	Buy	67,472	1.93 USD	$130.2K	conv 41	SEC
Spyre Therapeutics, Inc.Listing on record	Mar 15, 2022	Buy	34,777	2.06 USD	$71.6K	conv 47Cluster	SEC
Spyre Therapeutics, Inc.Listing on record	Feb 22, 2022	AwardD (derivative)	350,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Spyre Therapeutics, Inc.Listing on record	Feb 14, 2022	Gift	-57,450	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Spyre Therapeutics, Inc.Listing on record	Feb 14, 2022	Gift	175,036	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Spyre Therapeutics, Inc.Listing on record	Feb 14, 2022	Gift	-175,036	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Spyre Therapeutics, Inc.Listing on record	Feb 14, 2022	Gift	-10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Spyre Therapeutics, Inc.Listing on record	Feb 14, 2022	Gift	57,450	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Generation Bio Co.Listing unverified	Feb 9, 2026	OtherD (derivative)	-1,920	—	n/a (No price was disclosed in the filing)		SEC
Generation Bio Co.Listing unverified	Feb 9, 2026	OtherD (derivative)	-6,000	—	n/a (No price was disclosed in the filing)		SEC
Generation Bio Co.Listing unverified	Feb 9, 2026	OtherD (derivative)	-1,500	—	n/a (No price was disclosed in the filing)		SEC
Generation Bio Co.Listing unverified	Feb 9, 2026	Other	-29,928	—	n/a (No price was disclosed in the filing)		SEC
Generation Bio Co.Listing unverified	Feb 9, 2026	OtherD (derivative)	-2,500	—	n/a (No price was disclosed in the filing)		SEC
Generation Bio Co.Listing unverified	Feb 9, 2026	OtherD (derivative)	-3,000	—	n/a (No price was disclosed in the filing)		SEC
Generation Bio Co.Listing unverified	Feb 9, 2026	Other	-7,283	—	n/a (No price was disclosed in the filing)		SEC
Generation Bio Co.Listing unverified	Feb 9, 2026	OtherD (derivative)	-5,200	—	n/a (No price was disclosed in the filing)		SEC
Generation Bio Co.Listing unverified	Jun 6, 2025	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Generation Bio Co.Listing unverified	Jan 14, 2025	Buy	125,791	0.96 USD	$120.8K	conv 64First in 12mo	SEC
Generation Bio Co.Listing unverified	Jan 14, 2025	Buy	85,000	0.97 USD	$82.5K	conv 36	SEC
Generation Bio Co.Listing unverified	Jun 10, 2024	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Generation Bio Co.Listing unverified	Dec 5, 2023	Buy	88,495	1.41 USD	$124.8K	conv 62ClusterFirst in 12mo	SEC
Generation Bio Co.Listing unverified	Jun 12, 2023	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Generation Bio Co.Listing unverified	Jun 13, 2022	AwardD (derivative)	19,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Spyre Therapeutics, Inc.Listing on record	Mar 18, 2022	Buy	80,079	2.34 USD	$187.4K	conv 43	SEC
Spyre Therapeutics, Inc.Listing on record	Mar 15, 2022	Buy	42,417	1.86 USD	$78.9K	conv 35	SEC
Spyre Therapeutics, Inc.Listing on record	Mar 15, 2022	Buy	67,472	1.93 USD	$130.2K	conv 41	SEC
Spyre Therapeutics, Inc.Listing on record	Mar 15, 2022	Buy	34,777	2.06 USD	$71.6K	conv 47Cluster	SEC
Spyre Therapeutics, Inc.Listing on record	Feb 22, 2022	AwardD (derivative)	350,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Spyre Therapeutics, Inc.Listing on record	Feb 14, 2022	Gift	-57,450	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Spyre Therapeutics, Inc.Listing on record	Feb 14, 2022	Gift	175,036	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Spyre Therapeutics, Inc.Listing on record	Feb 14, 2022	Gift	-175,036	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Spyre Therapeutics, Inc.Listing on record	Feb 14, 2022	Gift	-10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Spyre Therapeutics, Inc.Listing on record	Feb 14, 2022	Gift	57,450	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC